We are live on ! Find out more
CA

CoreCap Advisors Portfolio holdings

AUM $3.39B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+31.21%
3 Year Est. Return
+83.55%
5 Year Est. Return
10 Year Est. Return
AUM
$1.19B
AUM Growth
-$92.6M
Cap. Flow
-$25M
Cap. Flow %
-2.1%
Top 10 Hldgs %
29.31%
Holding
2,370
New
6
Increased
293
Reduced
214
Closed
1,809

Sector Composition

Rank Sector Weight
1 Miscellaneous 81.47%
2 Technology 3.52%
3 Healthcare 2.9%
4 Consumer Staples 2.72%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AX icon
651
Axos Financial
AX
$5.19B
-21
Closed -$1K
AXON
652
Axon Enterprise
AXON
$36.8B
-1,186
Closed -$110K
AXS icon
653
AXIS Capital
AXS
$7.3B
-51
Closed -$3K
AYI icon
654
Acuity Brands
AYI
$8.97B
-5
Closed -$1K
AZN icon
655
AstraZeneca
AZN
$258B
-247
Closed -$33K
AZUL
656
DELISTED
Azul
AZUL
-1,969
Closed -$14K
BALL icon
657
Ball Corp
BALL
$16.1B
-658
Closed -$45K
BAR icon
658
GraniteShares Gold Shares
BAR
$1.41B
-7
Closed
BAX icon
659
Baxter International
BAX
$11.9B
-667
Closed -$43K
BB icon
660
BlackBerry
BB
$4.65B
-300
Closed -$2K
BBAX icon
661
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.75B
-40
Closed -$2K
BBCA icon
662
JPMorgan BetaBuilders Canada ETF
BBCA
$11.1B
-113
Closed -$7K
BBDC icon
663
Barings BDC
BBDC
$936M
-988
Closed -$9K
BBEU icon
664
JPMorgan BetaBuilders Europe ETF
BBEU
$9.21B
-110
Closed -$5K
BBH icon
665
VanEck Biotech ETF
BBH
$475M
-3
Closed
BBHY icon
666
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$621M
-225
Closed -$10K
BBJP icon
667
JPMorgan BetaBuilders Japan ETF
BBJP
$19.8B
-71
Closed -$3K
BBWI icon
668
Bath & Body Works
BBWI
$3.47B
-1,430
Closed -$39K
BBY icon
669
Best Buy
BBY
$19.8B
-205
Closed -$13K
BCC icon
670
Boise Cascade
BCC
$2.64B
-673
Closed -$40K
BCE icon
671
BCE
BCE
$20.8B
-110
Closed -$5K
BCI icon
672
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.48B
-74
Closed -$2K
BCLI
673
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-9
Closed
BCS icon
674
Barclays
BCS
$85.9B
-691
Closed -$5K
BCSF icon
675
Bain Capital Specialty
BCSF
$733M
-346
Closed -$5K

Similar funds

CoreCap Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, CoreCap Advisors held 2,370 positions worth $1.19B, down 7.2% from $1.28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

CoreCap Advisors's Q3 2022 filing shows 6 new, 293 increased, 214 reduced and 1,809 closed positions. Its largest new stake was AGF US Market Neutral Anti-Beta Fund: 116,760 shares worth $2.37M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $13.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 80% a quarter earlier, followed by Technology and Healthcare.

  • CoreCap Advisors's largest Q3 2022 buy was AGF US Market Neutral Anti-Beta Fund: 116,760 shares worth $2.37M.
  • CoreCap Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q3 2022, an estimated $22.1M increase.
  • CoreCap Advisors's biggest Q3 2022 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $13.9M.
  • CoreCap Advisors fully exited Incyte in Q3 2022, selling an estimated $1.52M.
  • CoreCap Advisors's ten largest holdings make up 29% of its $1.19B portfolio in Q3 2022.
  • CoreCap Advisors opened 6 new positions and closed 1,809 in Q3 2022.
  • CoreCap Advisors's portfolio value fell 7.2% quarter-over-quarter to $1.19B.

Based on CoreCap Advisors's 13F filing for Q3 2022, filed 10 Feb 2023.